Oliver Schacht
About Oliver Schacht
Oliver Schacht serves as the Executive Vice President of Corporate Development at OpGen, Inc. He has extensive experience in the biotechnology sector, having held various leadership roles, including Managing Director at Curetis GmbH and President and CEO at OpGen, Inc.
Current Role at OpGen
Oliver Schacht serves as the Executive Vice President of Corporate Development at OpGen, Inc. since 2024. In this role, he is responsible for overseeing strategic initiatives and corporate transactions. His leadership is pivotal in guiding the company's growth and development in the biotechnology sector.
Leadership at Curetis GmbH
Schacht has been the Managing Director of Curetis GmbH since 2011. His tenure has included significant contributions to the company's strategic direction and operational management. He previously held the position of CEO at Curetis from 2015 to 2020, where he played a crucial role in the company's development.
Education and Expertise
Oliver Schacht holds a PhD and MPhil from the University of Cambridge, where he studied management, strategic alliances, and biotechnology. He also earned a BA in European Business from ESB Business School, Reutlingen University. His educational background provides a strong foundation for his extensive career in the biotechnology industry.
Merger and Acquisition Experience
Schacht played a key role in the merger and acquisition between OpGen and Curetis in 2020. His expertise in strategic transactions has been instrumental in raising over $90 million in equity capital for OpGen on Nasdaq between 2020 and 2024.
Board Memberships and Contributions
Oliver Schacht has held various board positions, including Vice Chairman of the Board at the International Council of Biotechnology Associations (ICBA) from 2021 to 2022 and currently serves as Chairman of the Board since 2022. He has also contributed to significant transactions as a board member for companies like Protagen and evorion.